SVAS BIOSANA
Identification
Instrument name
SVAS BIOSANA
Symbol
SVS
ISIN code
IT0005469264
Code LEI
81560055A88E1D16D537
Exchange / Market
Euronext Growth
Trading location
Milan
ICB
20102015 Medical Supplies
Operation
IPO date
do 09/12/2021
IPO price
EUR 12.50
IPO type
Private placement
Capital raised
EUR 23 million
Bedrijfsprofiel
Svas Biosana S.p.A. is specialized in the manufacture and distribution of medical devices for public and private health institutions. The group's business is organized around 2 poles:
- production and sale of medical devices (Svas Biosana, Medical and FARMEX): incontinence aids, dressings, hygiene and personal care products, procedural packs for operating rooms, surgical instruments, infusion and suction systems, etc.;
- distribution of medical devices (Mark Medical): business operations conducted in Slovenia, Croatia, Bosnia-Herzegovina and Serbia.
Bron:
Cofisem
-
laatste update:
15 Oct 2024
Bestuurders
Chief Executive Officer | Umberto Perillo | ||||
Head of Investor Relations | Andrea Efficace | ||||
Bron: Cofisem - laatste update: 15 Oct 2024 |
Kerncijfers
Millenium | 2023 | 2022 | 2021 | 2020 | 2019 |
---|---|---|---|---|---|
Net sales | 118.284 | 97.227 | 81.085 | 76.044 | 73.574 |
Consumed purchases | 72.112 | 56.398 | 44.740 | 40.637 | 39.518 |
Labour costs | 13.763 | 12.676 | 11.022 | 11.386 | 11.281 |
Operating profit | 8.567 | 6.257 | 5.771 | 5.096 | 5.185 |
Income tax | 1.672 | 1.085 | 857 | 696 | 743 |
Net income | 5.126 | 3.571 | 3.161 | 2.514 | 2.484 |
Net income (Group share) | 5.123 | 3.569 | 3.159 | 2.513 | 2.483 |
Fiscal year end | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
Length of fiscal year (month) | 12 | 12 | 12 | 12 | 12 |
Currency & Unit | EUR - thousands | EUR - thousands | EUR - thousands | EUR - thousands | EUR - thousands |
Account Standards | Local GAAP | Local GAAP | Local GAAP | Local GAAP | Local GAAP |
Bron: Cofisem - laatste update: 15 Oct 2024 |